While studies of human and bovine endothelial nitric oxide synthase (eNOS) demonstrate activation by Ca2+ /calmodulin, recent progress demonstrates that eNOS phosphorylation can alter sensitivity to intracellular free calcium ([Ca2+]). The sheep, however, is widely used as a model for cardiovascular adaptation to pregnancy and ovine uterine artery endothelial cell (UAEC) eNOS undergoes pregnancy-specific (P) enhancement of activity associated with increased Ca2+ and protein kinase signaling in response to a number of agonists, including adenosine triphosphate (ATP). The degree of homology between the ovine and human full-length cDNAs was not previously known and yet is necessary to determine the validity in using an ovine model to study human physiology. The objectives of this study were to isolate and validate the clone of ovine eNOS cDNA and investigate ovine eNOS activation when expressed in COS-7 cells. The ovine eNOS cDNA has high homology to published human and bovine sequences and shares identity with the bovine amino acid sequence. When ovine eNOS was transiently expressed in COS-7 cells (COS-7/oeNOS), A23187 increased specfic catalytic activity in a dose- and time-dependent manner. A23187-stimulated activation of eNOS was, however, also accompanied by phosphorylation of eNOS S1179 and dephosphorylation of T497, demonstrating that an increase in [Ca2+]i may not be the sole mechanism of activation. The physiologic relevance of this was further underscored by the finding that ATP dose dependently increased peak [Ca2+]i and eNOS activity in COS-7/oeNOS, but also increased eNOS p-S1179 and decreased p-T497. This finding was similar to those in ovine P-UAEC treated with the Ca2+-mobilizing agonist ATP, wherein activation of eNOS was again concomitant with a rise p-S1179 as well as a slight decrease in p-T497. In conclusion, we describe the full-length ovine eNOS cDNA sequence and show that both physiologic and nonphysiologic calcium-mobilizing agents, which activate ovine eNOS in COS7 and PUAEC, do so in association with changes in eNOS phosphorylation. Given this information we can now begin to dissect the relationship between Ca2+ elevation and specflc phosphorylation events in eNOS activation in the ovine model, and thereby gain insight into the possible basis for pregnancy-related dysfunction.
1. Xiao D, Bird IM, Magness RR, Longo LD, Zhang L. Upregulation of eNOS in pregnant ovine uterine arteries by chronic hypoxia. Am J Physiol Heart Circ Physiol2001;280:H812-H820.
2.
2. Bird IM, Zhang L, Magness RR. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am J Physiol Regul Integr Comp Physiol2003;284:R245-R258.
3.
3. Yi FX, Magness RR, Bird IM. Simultaneous imaging of [Ca2+2]i and intracellular NO production in freshly isolated uterine artery endothelial cells: Effects of ovarian cycle and pregnancy. Am J Physiol Regul Integr Comp Physiol2005;288:R140-R148.
4.
4. Shaul PW, Smart EJ, Robinson LJ, et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem1996;271:6518-6522.
5.
5. Garcia-Cardena G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveohn. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem1997;272:25437-25440.
6.
6. Feron O, Michel JB, Sase K, Michel T. Dynamic regulation of endothehal nitric oxide synthase: Complementary roles of dual acylation and caveohn interactions. Biochemistry1998;37:193-200.
7.
7. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J Biol Chem1997;272:12030-12034.
8.
8. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem1997;272:25907-25912.
9.
9. Feron O, Saldana F, Michel JB, Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem1998;273:3125-3128.
10.
10. Fontana J, Fulton D, Chen Y, et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res2002;90:866-873.
11.
11. Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res2001;89:866-873.
12.
12. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem2000;275:22268-22272.
13.
13. Garcia-Cardena G, Fan R, Shah V, et al. Dynamic activation of endothehal nitric oxide synthase by Hsp90. Nature1998;392:821-824.
14.
14. Harris MB, Ju H, Venema VJ, et al. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem2001;276:16587-16591.
15.
15. Wedgwood S, Bekker JM, Black SM. Shear stress regulation of endothelial NOS in fetal pulmonary arterial endothelial cells involves PKC. Am J Physiol Lung Cell Mol Physiol2001;281:L490-L498.
16.
16. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature1999;399:601-605.
17.
17. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature1999;399:597-601.
18.
18. Gallis B, Corthals GL, Goodlett DR, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem1999;274:30101-30108.
19.
19. Michell BJ, Gnrffiths JE, Mitchelhill KI, et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol1999;9:845-848.
20.
20. Bird IM, Sullivan JA, Di T, et al. Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells. Endocrinology2000;141:1107-1117.
21.
21. Di T, Sullivan JA, Magness RR, Zhang L, Bird IM. Pregnancyspecific enhancement of agonist-stimulated ERK-1/2 signaling in uterine artery endothelial cells increases Ca(2+) sensitivity of endothelial nitric oxide synthase as well as cytosolic phospholipase A(2). Endocrinology2001;142:3014-3026.
22.
22. Bernier SG, Haldar S, Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothehal nitric-oxide synthase. J Biol Chem2000;275:30707-30715.
23.
23. Igarashi J, Michel T. Sphingosine 1-phosphate and isoformspecific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J Biol Chem2001;276:36281-36288.
24.
24. Sommer F, Klotz T, Steinritz D, et al. MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum. Int J Impot Res2002;14:217-225.
25.
25. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA. Modulation by peroxynitrite of Akt- and AMP-activated kinase dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem2002;277:32552-32557.
26.
26. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, Salt IP. Direct activation of AMP-activated protein kinase stimulates nitric oxide synthesis in human aortic endothelial cells. J Biol Chem2003;278:31629-31639.
27.
27. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res2001;88:E68-E75.
28.
28. Bae SW, Kim HS, Cha YN, Park YS, Jo SA, Jo I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun2003;306:981-987.
29.
29. Michell BJ, Chen Z, Tiganis T, et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem2001;276:17625-17628.
30.
30. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem2002;277:29669-29673.
31.
31. Boo YC, Hwang j, Sykes M, et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am j Physiol Heart Circ Physiol2002;283:H1819-H1828.
32.
32. Michell BJ, Harris MB, Chen ZP, et al. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric oxide synthase at serine 617 and serine 635. J Biol Chem2002;277:42344-42351.
33.
33. Gifford SM, Cale JM, Tsoi S, Magness RR, Bird IM. Pregnancyspecific changes in uterine artery endothelial cell signaling in vivo are both programmed and retained in primary culture. Endocrinology2003;144:3639-3650.
34.
34. Tsoi SC, Wen Y, Chung JY, Chen D, Magness RR, Zheng J. Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells. Mol Cell Endocrinol2002;196:95-106.
35.
35. Sessa WC, Harrison JK, Barber CM, et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem1992;267:15274-15276.
36.
36. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A1992;89:6348-6352.
37.
37. Nishida K, Harrison DG, Navas JP, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest1992;90:2092-2096.
38.
38. Searles CD, Miwa Y, Harrison DG, Ramasamy S. Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res1999;85:588-595.
39.
39. Alonso J, Sanchez de Miguel L, Monton M, Casado S, Lopez Farre A. Endothelial cytosolic proteins bind to the 3' untranslated region of endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha. Mol Cell Biol1997;17:5719-5726.
40.
40. Liu J, Sessa WC. Identification of covalently bound aminoterminal myristic acid in endothelial nitric oxide synthase. J Biol Chem1994;269:11691-11694.
41.
41. Lin MI, Fulton D, Babbitt R, et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem2003;278:44719-44726.
42.
42. Garritsen A, Zhang Y, Cooper DM. Purinergic receptor regulation of signal transduction in NCB-20 cells. Mol Pharmacol1992;41:743-749.
43.
43. Takahashi S, Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: Calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem2003;278:30821-30827.
44.
44. Wyatt AW, Steinert JR, Wheeler-Jones CP, et al. Early activation of the p42/p44MAPK pathway mediates adenosineinduced nitric oxide production in human endothelial cells: A novel calcium-insensitive mechanism. FASEB J2002;16:1584-1594.
45.
45. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain “calcium-independent” eNOS activation by phosphorylation. J Biol Chem2000;275:6123-6128.
46.
46. Fisslthaler B, Dirnmeler S, Hermann C, Busse R, Fleming I. Phosphorylation and activation of the endothehal nitric oxide synthase by fluid shear stress. Acta Physiol Scand2000;168:81-88.
47.
47. Matsubara M, Hayashi N, Jing T, Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem (Tokyo)2003;133:773-781.
